Educational content only. This post discusses general patterns in seller financing structures. Specific arrangements have legal, tax, and lending implications that vary considerably. Consult an accountant and lawyer experienced in practice transactions before structuring seller financing.
In a meaningful share of healthcare practice acquisitions, the buyer doesn't pay the full purchase price at closing. The seller holds a portion of the price as a note — a loan from seller to buyer that's repaid over time. This structure, commonly called seller financing or a seller note, is widely used for specific structural reasons that benefit both parties in many transactions.
This post covers how seller financing typically works, why it appears in so many deals, the trade-offs for each side, and the structural considerations that matter when seller financing is on the table.
How Seller Financing Works
The basic mechanics: at closing, the buyer pays a portion of the purchase price in cash (typically funded through their own equity and a primary commercial loan). The remaining portion of the purchase price is converted into a note — a promissory note from buyer to seller specifying the principal amount, interest rate, repayment schedule, and security.
The seller note is typically subordinated to the primary commercial loan. The bank that financed the bulk of the acquisition has first claim on practice assets in case of default; the seller's claim is junior to the bank's.
The buyer makes monthly payments to the seller throughout the note term, typically 5 to 10 years for healthcare practice transactions. Once the note is fully repaid, the seller's interest in the practice is concluded.
The size of the seller note varies. Common ranges for healthcare practice transactions: 5 to 15 percent of the total purchase price, though some transactions involve larger seller-financed components and others none at all.
Why Seller Financing Appears in So Many Deals
Several specific dynamics make seller financing useful structurally.
It bridges valuation gaps. Sellers and buyers often have different views of practice value. The seller might believe the practice is worth $1.4 million; the buyer's lender might be willing to finance based on $1.2 million. A seller note for the $200,000 difference can bridge this gap, allowing the deal to close at a number both sides accept.
It signals seller confidence. A seller willing to leave $200,000 in the practice for 5 to 7 years is implicitly confirming that the practice will continue to perform. Sellers who try to extract every dollar at closing — refusing any seller note — sometimes signal concerns about the practice's continued viability that buyers should pay attention to.
It enables transactions that otherwise wouldn't close. Buyers with limited equity injection can sometimes complete acquisitions through structures that include seller notes, where pure bank financing wouldn't have approved. SBA lending in the US specifically permits seller notes to count toward equity injection requirements in some circumstances, allowing buyers to acquire practices with less out-of-pocket capital.
It provides ongoing seller economics. The seller continues to receive income from the practice through note payments after closing. For sellers transitioning to retirement, this provides predictable income during the transition period.
It aligns transition incentives. A seller holding a note has economic interest in the practice's continued performance. They have natural incentive to support the transition fully, ensure patient retention, and help the buyer succeed.
Buyer Perspective on Seller Financing
From the buyer's side, seller notes have specific advantages and considerations.
Lower cash requirement at closing. The buyer needs less cash at closing because not all of the purchase price is being paid immediately. This is particularly valuable for buyers with limited equity who would otherwise be unable to complete the transaction or would face onerous loan terms.
Lender perspective on seller notes. Banks and SBA lenders in the US generally view seller notes positively when properly structured. The seller's continued financial interest in the practice's performance signals confidence the lender finds reassuring. Some SBA programs specifically permit seller notes to count toward minimum equity injection.
Transition support. The seller's continued economic stake in the practice typically produces stronger transition support than would occur in an all-cash deal. Sellers who have been paid in full and exited completely have less reason to actively support the buyer's success.
Cost considerations. Seller notes typically carry interest rates similar to or slightly higher than commercial loan rates. The buyer is paying interest on the seller-financed portion just as they would on a bank-financed portion. The total financing cost depends on the interest rate negotiated in the seller note relative to alternative financing the buyer could access.
Repayment structure. Seller notes are typically structured with monthly payments matching practice cash flow capability. The buyer's debt service obligation includes both bank loan payments and seller note payments. Combined debt service needs to fit within the practice's DSCR capacity.
Seller Perspective on Seller Financing
From the seller's side, the trade-offs are different.
Tax treatment. Seller financing can produce favourable tax treatment in some structures. Installment sale treatment in the US allows the seller to recognize gain on the seller-financed portion as payments are received rather than entirely in the year of sale. This can spread tax liability across multiple years and potentially keep the seller in lower tax brackets. Canadian tax treatment differs but similar deferral mechanisms exist in some structures. A CPA experienced in practice transactions should advise on specific tax implications.
Continued risk exposure. The seller retains economic exposure to the practice through the note. If the buyer can't make payments — due to practice underperformance, buyer financial issues, or other reasons — the seller may not collect the full note value. The seller's recourse depends on note structure, security, and lender subordination.
Income vs. capital. A seller who receives full payment at closing has the proceeds immediately available for investment, retirement, or other uses. A seller who receives note payments over 7 years has less liquidity but a steady income stream over that period. Which is preferable depends on the seller's personal financial situation.
Negotiating leverage on price. Sellers willing to provide seller financing often achieve higher purchase prices than sellers requiring all cash. The financing flexibility creates room for the price negotiation.
Structuring Considerations
Several specific structural elements matter when seller financing is being negotiated.
Interest rate. Typically negotiated within market context. A seller note at 6 percent interest in a market where commercial loans are running at 8 percent is generous to the buyer. A seller note at 10 percent is generous to the seller. Setting the rate at or near market commercial rates is most common.
Repayment term. Common terms run 5 to 10 years for healthcare practice seller notes. Longer terms reduce monthly payment burden but extend the seller's risk exposure. Shorter terms accelerate seller payment but increase the buyer's monthly debt service.
Repayment schedule. Most seller notes use standard monthly amortization. Some include initial interest-only periods, balloon payments, or other structural variations. Each variation has implications for both parties.
Subordination. The seller note is typically subordinated to the primary commercial lender's claim. The subordination terms specify how that subordination operates — under what circumstances seller payments can continue, what happens in default situations, and how proceeds are distributed if the practice has to be liquidated.
Security. What the seller note is secured against. Practice assets are typically pledged to the primary commercial lender first. The seller's security may be subordinated, may be limited to specific assets, or may rely primarily on personal guarantees from the buyer.
Personal guarantees. Most seller notes require personal guarantees from the buyer, similar to commercial bank loans. The guarantee scope and conditions are negotiable.
Default provisions. What constitutes default under the seller note, and what the seller's remedies are. Cross-default provisions with the commercial loan are common — default on the bank loan automatically defaults the seller note.
Prepayment. Can the buyer prepay the seller note, and under what terms? Some sellers want certain interest income guaranteed; others welcome prepayment. The terms vary.
When Seller Financing Doesn't Work
Several scenarios commonly produce friction or failure in seller-financed transactions.
Buyer underperformance. The practice doesn't perform at expected levels post-acquisition. The buyer can't service combined debt obligations. Note payments to the seller are delayed or missed. The transaction enters dispute or default.
Insufficient subordination structure. When subordination provisions aren't clear, conflicts can emerge between the bank lender and the seller about what payments can continue under stress. Unresolved subordination questions create operational complications during difficult periods.
Inadequate security. Seller notes that aren't adequately secured can leave the seller with limited recourse if buyer financial position deteriorates. The seller's protection depends on the security structure being robust.
Unrealistic expectations on either side. Sellers who expect to be paid like clockwork while the buyer faces practice challenges, or buyers who expect seller note flexibility the documentation doesn't permit, create relationship friction that can damage the transition.
Tax structure miscalculation. Tax planning that's not coordinated with the transaction structure can produce unexpected tax outcomes for the seller. The interaction between cash payments, note payments, and tax treatment requires coordinated planning.
The Practical Reality
Seller financing is common in healthcare practice transactions because it solves real structural problems for many deals. It bridges valuation gaps, signals seller confidence, enables transactions that wouldn't otherwise close, provides tax planning flexibility, and aligns incentives during transition.
It's not appropriate for every transaction. Sellers with strong cash needs at closing may not want it. Buyers with adequate equity and financing may not need it. Practices being sold to sophisticated institutional buyers (DSOs, large groups) often don't include it because the buyer's financing structure doesn't accommodate it.
When seller financing is on the table, the structure is among the most consequential elements of the transaction. The interest rate, term, subordination, security, and default provisions all materially affect outcomes for both parties. Working with experienced legal and tax advisors to structure these provisions properly is among the higher-leverage uses of professional services in a practice transaction.
The Capital Structure Tool compares four capital stack scenarios for financing a practice — all cash, cash plus business loan, cash plus loan plus equipment lease, or cash plus equipment lease only. While the tool doesn't specifically model seller note + bank loan combinations as a distinct scenario, the rate and term inputs let you approximate combined financing economics by modeling a primary loan structure with parameters that account for both components. The Practice Valuation Reference produces an implied valuation range that helps frame what overall purchase price is consistent with published patterns.
Disclaimer: Seller financing structures and patterns described are drawn from published practice transaction sources and represent general patterns. Specific arrangements have legal, tax, and lending implications. KlinDeck is not a lawyer, accountant, or financial advisor. Content is educational only.